|
所在平台: Udemy |
课程主页: https://www.udemy.com/course/survival-guide-to-stem-cell-research-and-therapies/
课程评论：没有评论
课程名称：干细胞研究与治疗生存指南 课程概述：干细胞研究与治疗生存指南为希望了解涉及人类干细胞的现有治疗选项的人士提供了全面的资源材料、文献库和登记资料的指导。 课程内容： 1. **潜力**：首先介绍干细胞在研究、药物测试和治疗中的现有应用，并讲解转移所需的操作过程以使治疗成为可能。 2. **分类**：干细胞的来源及其向不同细胞类型分化的能力决定了不同类型干细胞的典型用途。 3. **临床研究**：本部分将介绍两个重要的临床试验登记：NIH ClinicalTrials.gov 和 WHO 国际临床试验注册平台。该项目旨在让学员获得从登记和文献库中收集、整理相关信息并解读发现的实践经验，同时包括实时互动环节，允许学员提问并获得额外指导。 4. **患者需求**：本节简要介绍与市场宣传、客观结果指标、广告策略以及患者自主权相关的挑战。 5. **监管与法律框架**：干细胞治疗在世界各国的监管情况不同。本节将关注影响美国和欧盟的干细胞研究及治疗的相关规定，并探讨中国近期颁布的新伦理指南及其对干细胞诊所的管理政策。 6. **专业协会**：最后一部分解释了专业协会在干细胞研究与治疗中的作用。 该课程旨在为参与者提供必要的知识和技能，以便更好地理解干细胞研究和治疗的复杂性及其相关的法律和伦理框架。
Survival guide to stem cell research and therapies provides comprehensive guidance to publicly available resource materials, libraries and registries for people who are interested in understanding currently available treatment options involving human stem cells.POTENTIAL: The first section explains how stem cells are currently used in research, drug testing, and therapy, and how they have to be manipulated before transfer to make any treatments possible. CLASSIFICATION: Origin and ability of stem cells to differentiate into different cell types determines how different types of stem cells are typically used. CLINICAL RESEARCH: In this section, we will introduce two most important registries of clinical trials: NIH registry ClinicalTrials gov and WHO International Clinical Trials Registry Platform. A project is part of this section to give students the opportunity to get hands on experience with collecting and collating relevant information from registries and libraries, and interpretation of the findings. Real time interactive sessions are included to allow students to ask questions and offer additional guidance. PATIENT DEMAND: In this section, we briefly introduce challenges relating to marketing claims, objective outcome measures, advertising strategies and patient autonomy. REGULATORY AND LEGAL FRAMEWORK: Stem cell therapies are regulated differently in various countries around the world. In this section, we will focus on regulations that govern stem cell research and therapies in the U.S. and in the European Union. Policies on stem cell research are driven by ethical concerns relating to research that utilizes human embryos. China recently announced new ethical guidelines and new rules for their stem cell clinics, regulating both trials and treatments. PROFESSIONAL SOCIETIES: The last section explains the role of professional societies in stem cell research and therapies.
